Natan Ponieman - Spark Newswire

2 minute read

Psychedelics Biotech Startup Launches Phase 1 Study On Ayahuasca’s Active Ingredient

Today, 2:40 PM

Psychedelics biotech startup Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) announced the approval by the local Dutch ethics committee for a Phase 1 clinical trial evaluating the pharmacokinetics, pharmacodynamics and safety profile of the psychedelic compound DMT.

CSE:ENBI

2 minute read

New Psychedelics ETF Launches On NYSE Arca

By Natan Ponieman

Today, 2:40 PM

Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK) tracks the Enhanced Consciousness Index.

ATAI

2 minute read

Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants

By Natan Ponieman

Today, 2:40 PM

Health Canada has allowed a phase 2 clinical trial of psilocybin in patients currently undergoing treatment with traditional antidepressants.

CYBN

5 minute read

Psyched: UK Streamlines MDMA Therapy, FDA OKs MindMed’s First LSD Trial In 40 years, Atai Launches Subsidiary

By Natan Ponieman

Today, 2:40 PM

The Week In Psychedelics

ATAI

2 minute read

Lockup Period For 35% Of The Parent Company Shares Extended Until 2023 By Company Insiders

By Natan Ponieman

Today, 2:40 PM

TPCO Holding Corp. (NEO: GRAM.U) (OTCQX: GRAMF), also known as The Parent Company, announced that company insiders have voluntarily extended their lockup agreements for approximately 35% of the company's common shares, which would have ended on Friday.

GRAMF

2 minute read

Cannabis Analyst Advises Not To Buy WeedMaps Shares Until March

By Natan Ponieman

Today, 2:40 PM

Cantor Fitzgerald has issued a new report on cannabis tech platform WeedMaps (NASDAQ: MAPS), also known as WM Technology Inc.

MAPS

4 minute read

Psyched: Eleusis To Go Public Via Merger, New Psychedelics Bills In Utah, Virginia, Kansas And Missouri

By Natan Ponieman

Today, 2:40 PM

Psychedelics Legalization Gains Momentum Around The Country: Bills Introduced In Utah, Virginia, Kansas And Missouri A wave of psychedelics legislation continues to sweep across the country.

CMPS

1 minute read

MindMed Launches Study Using Monitoring System For Psychedelic Experiences

By Natan Ponieman

Today, 2:40 PM

Psychedelics biotech company MindMed (NASDAQ: MNMD) has enrolled the first subjects into its Session Monitoring System study. The company’s Session Monitoring System is a technology platform that can collect sensory data during a therapy session with a psychedelic drug.

MNMD

2 minute read

Psychedelics Biotech Companies Mark New Milestones In Drug Development Pipelines: Field Trip, Cybin and Wesana

By Natan Ponieman

Today, 2:40 PM

On Tuesday, three public companies in the psychedelics/biotech space announced significant milestones in their drug development pipelines.

CSE:WESA

2 minute read

Ketamine Therapy Shows Potential In Treatment Of Alcohol Use Disorder, New Study Finds

By Natan Ponieman

Today, 2:40 PM

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) published encouraging data from a Phase II trial looking at ketamine-assisted therapy for the treatment of alcohol use disorder.

AWKNF